Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial

Area of Science:

• Genomics
• Bioinformatics
• Oncology

Background:

• Large-scale gene expression data offers potential for identifying disease signatures.
• Technical variations in such data can lead to inaccurate findings.
• Removing technical variation while preserving biological signals is a significant challenge.

Purpose of the Study:

• To present a step-wise procedure for removing technical variation from gene expression data.
• To analyze the MINDACT microarray dataset to demonstrate the method's efficacy.
• To provide an adjusted dataset for advancing breast cancer research.

Main Methods:

• Analysis of the MINDACT microarray dataset, comprising 6693 breast cancer patients.
• Development and application of a procedure to remove technical variation.
• Validation of the method's ability to retain biological signals.

Main Results:

• A comprehensive analysis of the MINDACT dataset was performed.
• A method for removing technical variation from large-scale gene expression data was successfully applied.
• The adjusted dataset retains biological signals, essential for reliable discovery.

Conclusions:

• The developed procedure effectively removes technical variation from large gene expression datasets.
• The adjusted MINDACT dataset is a valuable resource for discovering and testing gene expression signatures in breast cancer.
• This work advances the understanding of breast cancer through improved data analysis techniques.